Programming – Vascular Discovery 2025

April 22–25, 2025
Marriott Baltimore Waterfront | Baltimore, Maryland

Vascular Discovery 2025 Schedule-at-a-Glance

All times are Eastern Daylight Time (UTC - 4)

Tuesday, April 22, 2025 schedule
Time	Activity
8:00 a.m. to 6:00 p.m.	Vascular Research Initiatives Conference (VRIC) Location: Waterview Ballroom, Ground Level This event is not part of the official Vascular Discovery Scientific Sessions as planned by the Program Committee. Separate registration is required to attend.
3:00 p.m. to 7:00 p.m.	Vascular Discovery Scientific Sessions Registration Location: Grand Ballroom Reg Desk, 3rd Level
6:00 p.m. to 8:00 p.m.	Poster Session 1 & Reception Location: Harborside Ballroom, 4th Level

Wednesday April 23 schedule
Time	Activity
7:00 a.m.	Registration Location: Grand Ballroom Reg Desk, 3rd Level Exhibits Location: Grand Foyer West, 3rd Level
7:00 a.m. to 8:00 a.m.	Continental Breakfast Location: Grand Foyer West, 3rd Level
7:00 a.m. to 8:00 a.m.	Early Career Training Session 1 - The Dos and Don'ts of Using AI in Grantmanship and Manuscript Writing Location: Grand Ballroom 6, 3rd Level
8:00 a.m. to 8:30 a.m.	Conference Opening Welcome Location: Grand Ballroom 1-5, 3rd Level Moderators: Kathleen Martin, PhD, Yale University School of Medicine Peter Henke, MD, University of Michigan 8:00 Welcome Remarks from AHA President Keith Churchwell, MD, Yale University School of Medicine 8:15 Welcome Remarks from the Program Chair Kathleen Martin, PhD, Yale University School of Medicine
8:30 a.m. to 10:00 a.m.	Plenary Session 1: Hot Topics in Cardiovascular Disease Location: Grand Ballroom 1-5, 3rd Level Moderators: Kathleen Martin, PhD, Yale University School of Medicine Peter Henke, MD, University of Michigan 8:30 Triglyceride-Rich Lipoproteins and Diabetes: Bridging the Gap Between Basic and Translational Research Karin Bornfeldt, PhD, University of Washington 9:00 Novel Mechanisms and Therapies for Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome Vicente Andrés, PhD, Centro Nacional de Investigaciones Cardiovasculares Carlos III 9:30 Keynote Lecture: The Not-So-Sweet Side of Artificial Sweeteners and Cardiovascular disease Stanley L. Hazen, MD, PhD, Lerner Research Institute-Cleveland Clinic
10:00 a.m. to 10:30 a.m.	BREAK/Exhibits Location: Grand Foyer West, 3rd Level
10:30 a.m. to 12:00 p.m.	Concurrent Session 1a: Mechanisms and Therapeutic Targets in Cardiovascular Disease Location: Grand Ballroom 1-5, 3rd Level Moderators: Jun Yu, MD, Temple University Eugene Chen, MD, PhD, University of Michigan 10:30 A New Genetic Model of Accelerated Coronary Atherosclerosis Joseph M. Miano, PhD, Augusta University 11:00 Inflammatory Cross-Talk in Atherosclerosis: Think Outside the Vessel Wall Katey Rayner, PhD, University of Ottawa Heart Institute 11:30 Targeting Endothelial CD45 Ameliorates Endothelial-to-Mesenchymal Transition in Atherosclerosis Qianman Peng, PhD, Harvard Medical School 11:37 Effects of pathogenic variation in ADAMTSL4 on vascular smooth muscle cell function relevant to spontaneous coronary artery dissection Cameron B. Pinnock, PhD, University of Michigan 11:44 Cilia protein IFT88 is required for smooth muscle cell growth factor signaling and phenotype switching Brendan O'Brien, PhD, Yale School of Medicine 11:51 Smooth Muscle Cells-Expressed Bmal1 Regulates Vascular Calcification Independent of the Canonical Circadian Pathway Ming He, UAB Medicine
10:30 a.m. to 12:00 p.m.	Concurrent Session 1b: Thrombosis: Signaling, Mechanisms & Function Location: Grand Ballroom 6, 3rd Level Moderators: Nirav Dhanesha, PhD, LSU Health Shreveport Michael Holinstat, PhD, University of Michigan 10:30 Mitochondrial Dynamics Shape Platelet Function, Hemostasis, and Thrombosis Jesse Rowley, PhD, University of Utah School of Medicine 11:00 Identification of an Immune Subset of Megakaryocytes that Present Major Histocompatibility Complex Class II Antigen and Directs T Cell Responses in the Bone Marrow Kellie Machlus, PhD, Boston Children’s Hospital 11:30 The Evaluation of Anti-Fibrotic and Anti-Thrombotic Effects of an Oral Galectin-3 Inhibitor in a Mouse Model of Venous Thrombosis Arnav Pandey, Soka University of America 11:37 Mitigating Sex-Specific Thrombotic Risk by Personalizing Thromboprophylaxis Isabella Ferlini Cieri, MD, Massachusetts General Hospital 11:44 Uncovering the Role of the Hsp40 Family Member, Cysteine String Protein-α, in Mouse Platelets Alexis N. Smith, PhD, Versiti Blood Research Institute 11:51 The functional roles of TGFβ signaling in regulating cardiac lymphangiogenesis and cardiac repair after myocardial ischemia Esteban A. Delgado, BS, Temple University
12:00 p.m. to 1:30 p.m.	The Mentor of Women Award Luncheon – Reset, Recharge, Rise: Resilience in the Face of Burnout and Setbacks Presented by the ATVB Women's Leadership Committee (ticket required) Location: Grand Ballroom 7-9, 3rd Level or PVD Annual Business Meeting and Business Luncheon (OFF SITE - ticket required) or Lunch on your own
1:30 p.m. to 3:00 p.m.	Plenary Session 2: Highlights from the ATVB Journal Location: Grand Ballroom 1-5, 3rd Level Moderators: Ann Marie Schmidt, MD, New York University Grossman School of Medicine Mark W. Majesky, PhD. University of Washington 1:30 Daniel Steinberg Early Career Investigator Award in Atherosclerosis/Lipoproteins Lauren Biwer, PhD, Yale School of Medicine 1:45 Karl Link Early Career Investigator Award in Thrombosis Tomoki Togashi, PhD, Kanazawa University 2:00 Werner Risau Early Career Investigator Award in Vascular Biology Ying Yang, PhD, University of South Florida 2:15 ATVB Journal Report Ann Marie Schmidt, MD, New York University Grossman School of Medicine 2:23 Dr. David A. Dichek Remembrance Mark W. Majesky, PhD, University of Washington 2:40 David A Dichek Mid-Career Investigator Award Lecture Hong S. Lu, MD, PhD, University of Kentucky
3:00 p.m. to 3:30 p.m.	Break/Exhibits Location: Grand Foyer West, 3rd Level
3:30 p.m. to 5:00 p.m.	Concurrent Session 2a: Shobha Ghosh Investigator in Training Award Competition & Hot Off the Bench Oral Abstracts Location: Grand Ballroom 1-5, 3rd Level Moderators: A. Phillip Owens III, PhD, University of Cincinnati Hanrui Zhang, PhD, Columbia University Medical Center 3:30 Deficiency of the smooth muscle-specific long non-coding RNA CARMN exacerbates thoracic aortic aneurysms induced by FBN1 gene mutations in Marfan syndrome Xiangqin He, PhD, Augusta University 3:42 Transcriptional Condensates Regulate Smooth Muscle Cell Phenotypic Switching Peiheng Gan, PhD, MBBS, UT Southwestern Medical Center 3:54 Post-Transcriptional Regulation of Metabolic Hepatokines in Obesity and Metabolism Heidi Schmidt, PhD, UCLA 4:06 Endothelial-Argonaute 1 (AGO1) Inhibition Confers Islet Protection in Diabetes Alonso Tapia, BS, City of Hope 4:18 Indoxyl Sulfate Suppresses GAS6 and Impairs Anti-Atherogenic Macrophage Function: A Novel Mechanism Driving Accelerated Atherosclerosis in Chronic Kidney Disease Prabhash Jha, PhD, MSc, Brigham and Women's Hospital Hot Off the Bench Oral Abstracts 4:30 TFAM Controls Endothelial Mitophagy to Revascularize Ischemic Muscle in Peripheral Artery Disease Vijay C. Ganta, PhD, Augusta University 4:37 Microplastic exposure elicits sex-specific atherosclerosis development in low-density lipoprotein receptor-deficient mice Ting-An Lin, University of California, Riverside 4:44 Liver-specific Deletion of Carnitine Palmitoyltransferase 1a Lowers Apolipoprotein B Containing Lipoproteins in Mice Robert Helsley, PhD, University of Kentucky 4:51 Genetic loss of a non-lipid handling CAD risk allele causes CAD in mice Amr Salem, VMD, PhD, LSU Health Shreveport
3:30 p.m. to 5:00 p.m.	Concurrent Session 2b: Metabolism in Cardiovascular Disease Location: Grand Ballroom 6, 3rd Level Moderators: Kerry-Anne Rye, PhD, University of New South Wales Hong Chen, PhD, Harvard Medical School 3:30 Altered cross talk between exocrine and endocrine pancreas as a novel risk for metabolic syndrome and atherosclerosis Arya Mani, MD, Yale University School of Medicine 4:00 Unveiling Novel Hepatic Metabolic Pathways as Dual Targets for MASH and Atherosclerosis Treatment Oren Rom, PhD,RD, LSU Health Shreveport 4:30 Harnessing Lipid Metabolism in Macrophages by Lysosomal-Mitochondrial Coupling to Treat Obesity Jun Huang, PhD, University of Pittsburgh 4:37 Development of Photoactivable apoE for In Vivo Tracking Michael Strickland, PhD, Washington University in Saint Louis 4:44 Hepatic Serine Hydroxymethyltransferase 2 Drives Atherosclerosis through One-Carbon Metabolic Regulation of VLDL and Ceramides Koral S. Richard, BA, BS, LSUHealth Shreveport 4:51 Targeting leucine metabolism in macrophages as a novel therapeutic strategy in atherosclerosis Xiangyu Zhang, PhD, University of Pittsburgh
5:00 p.m to 7:00 p.m.	Poster Session 2 & Reception Sponsored by the ATVB Journal Location: Harborside Ballroom, 4th Level

Thursday, April 24, 2025 schedule
Time	Activity
7:00 a.m.	Registration Location: Grand Ballroom Reg Desk, 3rd Level Exhibits Location: Grand Foyer West, 3rd Level
7:00 a.m. to 8:00 a.m.	Continental Breakfast Location: Grand Foyer West, 3rd Level
7:00 a.m. to 8:00 a.m.	Early Career Training Session 2 – Roundtable Events Location: Grand Ballroom 7-9, 3rd Level
8:00 a.m. to 9:30 a.m.	Plenary Session 3: Inflammation in Cardiovascular Diseases Location: Grand Ballroom 1-5, 3rd Level Moderators: Isabella M. Grumbach, MD, PhD, University of Iowa Chiara Giannarelli, MD, PhD, NYU Langone Health 8:00 Brain-Body Communication Regtulating Inflammation in Cardiovascular Disease Filip Swirski, PhD, The Cardiovascular Research Institute at Mount Sinai 8:30 Targeting Immune Checkpoints in Atherosclerosis: A Rebalancing Act Esther Lutgens, MD, PhD, Mayo Clinic 9:00 Clonal behaviors of neutrophils inside vessels Andres Hidalgo, PhD, Yale University School of Medicine
9:30 a.m. to 10:00 a.m.	BREAK/Exhibits Location: Grand Foyer West, 3rd Level
10:00 a.m. to 11:30 a.m.	Concurrent Session 3a: Apolipoproteins, Lipoproteins, and Lipid Mechanism Location: Grand Ballroom 1-5, 3rd Level Moderators: Karin Bornfeldt, PhD, University of Washington Mary Sorci-Thomas, PhD, Medical College of Wisconsin 10:00 Delivering Ciruclating Lipids into the Heart and Arterial Wall Ira J. Goldberg, MD, NYU Langone Health 10:30 Receptor-Based Approaches to Reducing Cardiovascular Risk Daisy Sahoo, PhD, Medical College of Wisconsin 11:00 Functional dissection of ANGPTL3 Sydney G. Walker, BS, University of Iowa 11:07 SURF4-containing Classical Vesicles Mediate Apolipoprotein(a)-ApolipoproteinB Secretory Trafficking Simon Ofiara, BSc, University of Western Ontario 11:14 Proteomic and Lipidomic Analysis of Mesenteric Lymph from Mice Before and After Duodenal Lipid Administration Khaga Neupane, PhD, University of Kentucky 11:21 Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights from Genetic and Experimental Models Yanhong Guo, MD, PhD, University Of Michigan
10:00 a.m. to 11:30 a.m.	Concurrent Session 3b: Translational Studies in Vascular Disease Location: Grand Ballroom 6, 3rd Level Moderators Kevin Southerland, MD, Duke University Jean Marie Ruddy, MD, Medical University of South Carolina 10:00 Mapping the genetics of FMD and SCAD: Matricellular effects in arterial dysplasia and dissections Santhi K. Ganesh, MD, University of Michigan 10:30 Creating lymphatic endothelial cells from induced pluripotent stem cells Katherine Hekman, MD, PhD, Emory University School of Medicine 11:00 Genomic Editing of a Pathogenic Mutation in the Alpha Actin Isotype 2 Gene Rescues a Severe Vascular Disease Qianqian Ding, PhD, UTSouthwestern Medical Center 11:07 PCSK9 Inhibition Attenuates Experimental Abdominal Aortic Aneurysm Formation Michael Fassler, MD, University of Florida 11:14 Intestinal degradation of trimethylamine by a novel gut bacterium reduces blood level of trimethylamine N-oxide, a risk factor for cardiovascular disease Sang Sun Yoon, PhD, Yonsei University 11:21 Exosomes carrying VEGF-A mRNA rescues ischemic tissue with low immunogenicity Andrew S. Lee, MD, PhD, Shenzhen Medical Academy of Research and Translation
11:30 a.m. to 1:00 p.m.	ATVB Diversity Committee Luncheon – Current State of Diversity Initiatives, What Now? - ticketed event Location: Grand Ballroom 7-9, 3rd Level
11:30 a.m. to 1:00 p.m.	Lunch on Your Own
1:00 p.m. to 3:00 p.m.	Plenary Session 4: Early Career Investigator Award Competition: Irvine H. Page Junior Faculty Research Award & Kenneth M. Brinkhous Early Career Investigator Award in Thrombosis Location: Grand Ballroom 1-5, 3rd Level Moderators: Wayne Orr, PhD, LSU Health Shreveport Esther Lutgens, MD, PhD, Mayo Clinic Milka Koupenova, PhD, UMass Chan Medical School Joseph E. Aslan, PhD, Oregon Health & Science University Irvine H. Page Junior Faculty Research Award Competition 1:00 Caloric Restriction-Induced Macrophages: A Potential New Therapy for Atherosclerosis Resolution Ada Weinstock, PhD, University of Chicago 1:15 Inhibition of MMAB Protects Against Diet-Induced Obesity and Atherosclerosis Leigh A. Goedeke, PhD, Mount Sinai 1:30 Novel epigenetic therapy for Smooth Muscle Dysfunction Syndrome Callie Kwartler, PhD, UTHSC-HOUSTON 1:45 The N-terminus of Apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells Ainara Gonzalez, PhD, New York University Langone Health Kenneth M. Brinkhous Early Career Investigator Award in Thrombosis Competition 2:00 VAMP8 Deficiency Attenuates AngII-Induced Abdominal Aortic Aneurysm Formation via Platelet Reprogramming and Enhanced ECM Stability Shayan Mohammadmoradi, PhD, University of Kentucky 2:15 Intraplatelet Protein Aggregates modulate Platelet Activation in Alzheimer’s Disease Kanika Jain, PhD, Yale University 2:30 Neutrophil extracellular traps do not drive immunothrombosis or immune dysregulation but do prevent sepsis-associated sequelae including kidney dissemination of Staphylococcus aureus in neutrophilic mice Kimberly Martinod, PhD, University of Rochester 2:45 Sex-Based Evaluation Of Aspirin Therapy In Murine DVT And Secondary DVT Prevention Aatira Vijay, PhD, Massachusetts General Hospital
3:00 p.m. to 3:30 p.m.	Break/Exhibits Location: Grand Foyer West, 3rd Level
3:30 p.m to 5:00 p.m.	Concurrent Session 4a: Mechanisms of Atherosclerosis, Inflammation & Immunity in the Vessel Wall Location: Grand Ballroom, 1-5, 3rd Level Moderators: Trevor P. Fidler, PhD, University of California-San Francisco Rama Natarajan, PhD, City of Hope 3:30 Smooth Muscle Cell Regulation in Vascular Disease Helle F. Jørgensen, PhD, University of Cambridge 4:00 Finding and Pushing the Limits of Macrophage Efferocytosis in Atherosclerosis Hanrui Zhang, PhD, Columbia University Medical Center 4:30 Macrophage-Expressed Olfr519 Regulates Inflammation and Drives Atherosclerosis Progression Marco Orecchioni, PhD, Augusta University 4:37 Long noncoding RNA regulation of NLRP3 inflammasome activation in atherosclerosis Morgane Gourvest, NYU Grossman school of Medicine 4:44 Single cell variant to enhancer to gene map for coronary artery disease Junedh Amrute, PhD, Washington University 4:51 BAF60c-mediated metabolo-epigenetic regulation of vascular smooth muscle cell dysfunction in atherosclerosis Guizhen Zhao, PhD, University of Houston
3:30 p.m to 5:00 p.m.	Concurrent Session 4b: Blood Coagulation in Health & Disease Location: Grand Ballroom 6, 3rd Level Moderators: Colin Evans, PhD, University of South Carolina John Hwa, MD, PhD, Yale University School of Medicine 3:30 Plasmin Generation Assays and the Role of Fibrinolysis in Venous Thrombosis Alisa S. Wolberg, PhD, UNC School of Medicine 4:00 Balancing Pro- and Anticoagulant Functions of Factor V: Clinical Insights and Therapeutic Strategies Rodney M. Camire, PhD, University of Pennsylvania Perelman School of Medicine 4:30 Plasminogen small RNA cargo promotes immunogenicity and inhibits enzymatic activity Kasey C. Vickers, PhD, Vanderbilt University Medical Center 4:37 Biodegradable PLGA Nanoparticles Modulate Monocyte/Macrophage Actions Reduce Vein Wall Fibrosis Oscar Y. Moreno, MD, University of Michigan 4:44 The Transition of Platelets from Sealants to Signalers in Abdominal Aortic Aneurysm Protection via TGFβ1 A. Phillip P. Owens III, PhD, University of Cincinnati 4:51 Plasminogen Activator Inhibitor-1 Deficiency Induces Cardiac Hemorrhage and Augments Cardiac Fibrosis, but not Aortic Aneurysm, in Angiotensin II-infused Mice Alex Pettey, BS, University of Kentucky
5:00 p.m. to 7:00 p.m.	Poster Session 3 and Reception Location: Harborside Ballroom, 4th Level
7:00 p.m. to 10:00 p.m.	Vascular Discovery Council Celebration -- OFFSITE & Ticket is required to attend

Friday, April 25, 2025 schedule
Time	Activity
7:30 a.m.	Registration Location: Grand Ballroom Reg Desk, 3rd Level
7:30 a.m. to 8:30 a.m.	Continental Breakfast Location: Grand Foyer West, 3rd Level
7:30 a.m. to 8:30 a.m.	Inside the AHA's Research Enterprise: Grant Funding and Other Opportunities Location: Grand Ballroom 6, 3rd Level Glenn Dillon, PhD, American Heart Association
8:30 a.m. to 9:15 a.m.	Plenary Session 5: Council Awards & Recognition Location: Grand Ballroom 1-5, 3rd Level
9:15 a.m. to 9:30 a.m.	BREAK Location: Grand Foyer West, 3rd Level
9:30 a.m. to 11:00 a.m.	Plenary Session 6: Invited Lecture Series Location: Grand Ballroom 1-5, 3rd Level Moderators: Kathleen Martin, PhD, Yale University School of Medicine Kiran Musunuru, MD, PhD, University of Pennsylvania 9:30 Vascular Discovery Distinguished Lecture: The Assembly and Secretion of apoB Lipoproteins: Many Unanswered Questions After 60 Years of Research Henry N. Ginsberg, MD, Irving Professor of Medicine, Columbia University Vagelos College of Physicians and Surgeons 10:00 Jeffrey M. Hoeg Arteriosclerosis, Thrombosis, and Vascular Biology Award for Basic Science and Clinical Research Sponsored by the Council on Arteriosclerosis, Thrombosis, and Vascular Biology Turning Trash to Treasure: Targeting Non-Coding RNAs in Diabetic Vascular Disease Mark W. Feinberg, MD, Professor of Medicine, Brigham and Women’s Hospital / Harvard Medical School 10:30 PVD Mid-Career Award and Lecture Sponsored by Council on Peripheral Vascular Disease Infection, Thrombosis and Coagulopathy Andrea T. Obi, MD, University of Michigan Medical Center
11:00 a.m. to 11:15 a.m.	Closing Remarks / Adjourn 11:00 Kathleen Martin, PhD, Yale University School of Medicine

2025 Speakers

Henry N. Ginsberg, MD, FAHA

Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University

Vascular Discovery Distinguished Lecturer
Presentation: The Assembly and Secretion of apoB Lipoproteins: Many Unanswered Questions After 60 Years of Research
9:30 a.m., Friday, April 25, 2025

Dr. Henry Ginsberg is the Irving Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons and Past Director of the Irving Institute for Clinical and Translational Research at the Columbia University Irving Medical Center in New York. He earned his medical degree at the State University of New York Downstate Medical Center in Brooklyn (1970), and completed training in internal medicine on the Boston University Service of the Boston City Hospital in Massachusetts (1970-1972). Dr. Ginsberg trained in Endocrinology and Metabolism at Stanford University (1972-74) under the tutelage of Gerald Reaven, one of the pioneers in studies of triglyceride metabolism, insulin resistance, and diabetes. He next completed a second postdoctoral fellowship in the laboratory of Virgil Brown and Daniel Steinberg (1976-78) where he was introduced to apolipoprotein B. In 1978, Dr. Ginsberg was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine. From 1985 until the present, he has been at Columbia.

During his time at Columbia, he has been PI of a T32 in Arteriosclerosis (1992-present), Director of an NCRR GCRC (1994-2006), and PI of an NCATS CTSA (2006-2017). His research, which was funded by NIH continually from 1980 to 2025, focused on the regulation of plasma lipid and lipoprotein levels, particularly the levels and metabolism of the apoB-containing lipoproteins, VLDL, IDL, and LDL, as well as HDL, in humans. He and his colleagues used radiolabeled lipoproteins and later, stably labeled amino acids and lipids to trace apoB, TG, and other apolipoproteins through the plasma, analyzing the data with compartmental models. He also has conducted studies in human and rodent hepatoma cells and in mouse models, focusing on the assembly of apoB with lipids to form VLDL and the role of insulin resistance and altered hepatic lipid metabolism on the assembly and secretion of VLDL. Dr. Ginsberg participated as a leader in many clinical trials and was the principal investigator on the Lipid Arm of the ACCORD trial (1998-2010). He has published over 300 peer-reviewed articles and more than 100 chapters and invited reviews. He has been an active member of ATVB committees, including as Chair of the Program Committee (1993-1996) and member, vice chair and chair of the Executive Committee (1999-2004). It was during the latter period that the leadership of the Arteriosclerosis and Thrombosis Councils merged with the Vascular Biology Working Group to created the ATVB Council. He has been recognized several times by AHA/ATVB, including being chosen to present the ATVB’s Lyman Duff Lecture in 2004 and the Council on Lifestyle and Cardiometabolic Health’s Robert Levy Lecture in 2014. Finally, Dr. Ginsberg, throughout his career, has had a small clinical practice caring for individuals with severe lipid disorders.

About this Meeting

This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.

Vascular Discovery 2025 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.

See the American Heart Association Policies and Guiding Values (PDF).

Target Audience

The conference will especially appeal to scientists and clinicians interested in:

Allergy and Immunology
Arteriosclerosis
Biochemistry
Biological Sciences
Diabetes and Metabolism
Functional Genomics
Genetics
Hematology
Internal Medicine
Molecular/Cellular Biology
Nutrition
Pathology
Peripheral Artery Disease
Pharmacology
Physiology
Vascular Surgery
Thrombosis
Vascular Biology
Vascular Medicine

Learning Objectives

At the conclusion of this conference, participants will be able to:

Discuss recent advances and emerging experimental models in ATVB and peripheral vascular diseases that target primary acquired diseases and/or secondary factors contributing to vascular-related disorders.
Summarize findings from recent translational research or clinical trials and the impact for future treatment and/or management of vascular-related disorders.
Describe best practices associated with ATVB scientific research and/or the management of patients with vascular-related diseases.